Global Covid-19 Vaccine Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 34199
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Covid-19 Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Covid-19 Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation

Covid-19 Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Covid-19 Vaccine market has been segmented into:

DNA

Non-replicating Viral Vector

Protein Subunit

RNA

Others

By Application, Covid-19 Vaccine has been segmented into:

Adults

Children

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Covid-19 Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Covid-19 Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Covid-19 Vaccine market.

The report offers in-depth assessment of the growth and other aspects of the Covid-19 Vaccine market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Covid-19 Vaccine Market Share Analysis

Covid-19 Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Covid-19 Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Covid-19 Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Covid-19 Vaccine are:

Moderna

Heat Biologics

Shenzhen Geno-Immune Medical Institute

CanSino Biologicals

Johnson_Johnson

Inovio Pharmaceuticals

Pfizer

GlaxoSmithKine

Sanofi

Among other players domestic and global, Covid-19 Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Covid-19 Vaccine Market Overview

1.1 Product Overview and Scope of Covid-19 Vaccine

1.2 Classification of Covid-19 Vaccine by Type

1.2.1 Global Covid-19 Vaccine Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global Covid-19 Vaccine Revenue Market Share by Type in 2019

1.2.3 DNA

1.2.4 Non-replicating Viral Vector

1.2.5 Protein Subunit

1.2.6 RNA

1.2.7 Others

1.3 Global Covid-19 Vaccine Market by Application

1.3.1 Overview: Global Covid-19 Vaccine Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Adults

1.3.3 Children

1.4 Global Covid-19 Vaccine Market by Regions

1.4.1 Global Covid-19 Vaccine Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of Covid-19 Vaccine (2015-2025)

1.4.3 North America (USA, Canada and Mexico) Covid-19 Vaccine Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) Covid-19 Vaccine Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Covid-19 Vaccine Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) Covid-19 Vaccine Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Covid-19 Vaccine Status and Prospect (2015-2025)

2 Company Profiles

2.1 Moderna

2.1.1 Moderna Details

2.1.2 Moderna Major Business

2.1.3 Moderna SWOT Analysis

2.1.4 Moderna Product and Services

2.1.5 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.2 Heat Biologics

2.2.1 Heat Biologics Details

2.2.2 Heat Biologics Major Business

2.2.3 Heat Biologics SWOT Analysis

2.2.4 Heat Biologics Product and Services

2.2.5 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.3 Shenzhen Geno-Immune Medical Institute

2.3.1 Shenzhen Geno-Immune Medical Institute Details

2.3.2 Shenzhen Geno-Immune Medical Institute Major Business

2.3.3 Shenzhen Geno-Immune Medical Institute SWOT Analysis

2.3.4 Shenzhen Geno-Immune Medical Institute Product and Services

2.3.5 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.4 CanSino Biologicals

2.4.1 CanSino Biologicals Details

2.4.2 CanSino Biologicals Major Business

2.4.3 CanSino Biologicals SWOT Analysis

2.4.4 CanSino Biologicals Product and Services

2.4.5 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.5 Johnson_Johnson

2.5.1 Johnson_Johnson Details

2.5.2 Johnson_Johnson Major Business

2.5.3 Johnson_Johnson SWOT Analysis

2.5.4 Johnson_Johnson Product and Services

2.5.5 Johnson_Johnson Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.6 Inovio Pharmaceuticals

2.6.1 Inovio Pharmaceuticals Details

2.6.2 Inovio Pharmaceuticals Major Business

2.6.3 Inovio Pharmaceuticals Product and Services

2.6.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.7 Pfizer

2.7.1 Pfizer Details

2.7.2 Pfizer Major Business

2.7.3 Pfizer Product and Services

2.7.4 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.8 GlaxoSmithKine

2.8.1 GlaxoSmithKine Details

2.8.2 GlaxoSmithKine Major Business

2.8.3 GlaxoSmithKine Product and Services

2.8.4 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

2.9 Sanofi

2.9.1 Sanofi Details

2.9.2 Sanofi Major Business

2.9.3 Sanofi Product and Services

2.9.4 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Covid-19 Vaccine Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 Covid-19 Vaccine Players Market Share

3.2.2 Top 10 Covid-19 Vaccine Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global Covid-19 Vaccine Revenue and Market Share by Regions

4.2 North America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

4.3 Europe Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

4.5 South America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

5 North America Covid-19 Vaccine Revenue by Countries

5.1 North America Covid-19 Vaccine Revenue by Countries (2015-2020)

5.2 USA Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

5.3 Canada Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

5.4 Mexico Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

6 Europe Covid-19 Vaccine Revenue by Countries

6.1 Europe Covid-19 Vaccine Revenue by Countries (2015-2020)

6.2 Germany Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

6.3 UK Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

6.4 France Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

6.5 Russia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

6.6 Italy Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Covid-19 Vaccine Revenue by Countries

7.1 Asia-Pacific Covid-19 Vaccine Revenue by Countries (2015-2020)

7.2 China Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

7.3 Japan Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

7.4 Korea Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

7.5 India Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

8 South America Covid-19 Vaccine Revenue by Countries

8.1 South America Covid-19 Vaccine Revenue by Countries (2015-2020)

8.2 Brazil Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

8.3 Argentina Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Covid-19 Vaccine by Countries

9.1 Middle East & Africa Covid-19 Vaccine Revenue by Countries (2015-2020)

9.2 Saudi Arabia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

9.3 UAE Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

9.4 Egypt Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

9.5 South Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global Covid-19 Vaccine Revenue and Market Share by Type (2015-2020)

10.2 Global Covid-19 Vaccine Market Forecast by Type (2019-2024)

10.3 DNA Revenue Growth Rate (2015-2025)

10.4 Non-replicating Viral Vector Revenue Growth Rate (2015-2025)

10.5 Protein Subunit Revenue Growth Rate (2015-2025)

10.6 RNA Revenue Growth Rate (2015-2025)

10.7 Others Revenue Growth Rate (2015-2025)

11 Global Covid-19 Vaccine Market Segment by Application

11.1 Global Covid-19 Vaccine Revenue Market Share by Application (2015-2020)

11.2 Covid-19 Vaccine Market Forecast by Application (2019-2024)

11.3 Adults Revenue Growth (2015-2020)

11.4 Children Revenue Growth (2015-2020)

12 Global Covid-19 Vaccine Market Size Forecast (2021-2025)

12.1 Global Covid-19 Vaccine Market Size Forecast (2021-2025)

12.2 Global Covid-19 Vaccine Market Forecast by Regions (2021-2025)

12.3 North America Covid-19 Vaccine Revenue Market Forecast (2021-2025)

12.4 Europe Covid-19 Vaccine Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific Covid-19 Vaccine Revenue Market Forecast (2021-2025)

12.6 South America Covid-19 Vaccine Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa Covid-19 Vaccine Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Covid-19 Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Covid-19 Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Covid-19 Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market Covid-19 Vaccine Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global Covid-19 Vaccine Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Moderna Corporate Information, Location and Competitors

Table 7. Moderna Covid-19 Vaccine Major Business

Table 8. Moderna Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 9. Moderna SWOT Analysis

Table 10. Moderna Covid-19 Vaccine Product and Solutions

Table 11. Moderna Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Heat Biologics Corporate Information, Location and Competitors

Table 13. Heat Biologics Covid-19 Vaccine Major Business

Table 14. Heat Biologics Covid-19 Vaccine Total Revenue (USD Million) (2018-2019)

Table 15. Heat Biologics SWOT Analysis

Table 16. Heat Biologics Covid-19 Vaccine Product and Solutions

Table 17. Heat Biologics Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Shenzhen Geno-Immune Medical Institute Corporate Information, Location and Competitors

Table 19. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Major Business

Table 20. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 21. Shenzhen Geno-Immune Medical Institute SWOT Analysis

Table 22. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions

Table 23. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. CanSino Biologicals Corporate Information, Location and Competitors

Table 25. CanSino Biologicals Covid-19 Vaccine Major Business

Table 26. CanSino Biologicals Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 27. CanSino Biologicals SWOT Analysis

Table 28. CanSino Biologicals Covid-19 Vaccine Product and Solutions

Table 29. CanSino Biologicals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Johnson_Johnson Corporate Information, Location and Competitors

Table 31. Johnson_Johnson Covid-19 Vaccine Major Business

Table 32. Johnson_Johnson Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 33. Johnson_Johnson SWOT Analysis

Table 34. Johnson_Johnson Covid-19 Vaccine Product and Solutions

Table 35. Johnson_Johnson Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Inovio Pharmaceuticals Corporate Information, Location and Competitors

Table 37. Inovio Pharmaceuticals Covid-19 Vaccine Major Business

Table 38. Inovio Pharmaceuticals Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 39. Inovio Pharmaceuticals SWOT Analysis

Table 40. Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions

Table 41. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Pfizer Corporate Information, Location and Competitors

Table 43. Pfizer Covid-19 Vaccine Major Business

Table 44. Pfizer Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 45. Pfizer SWOT Analysis

Table 46. Pfizer Covid-19 Vaccine Product and Solutions

Table 47. Pfizer Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. GlaxoSmithKine Corporate Information, Location and Competitors

Table 49. GlaxoSmithKine Covid-19 Vaccine Major Business

Table 50. GlaxoSmithKine Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 51. GlaxoSmithKine SWOT Analysis

Table 52. GlaxoSmithKine Covid-19 Vaccine Product and Solutions

Table 53. GlaxoSmithKine Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Sanofi Corporate Information, Location and Competitors

Table 55. Sanofi Covid-19 Vaccine Major Business

Table 56. Sanofi Covid-19 Vaccine Total Revenue (USD Million) (2017-2018)

Table 57. Sanofi SWOT Analysis

Table 58. Sanofi Covid-19 Vaccine Product and Solutions

Table 59. Sanofi Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Global Covid-19 Vaccine Revenue (Million USD) by Players (2015-2020)

Table 61. Global Covid-19 Vaccine Revenue Share by Players (2015-2020)

Table 62. Global Covid-19 Vaccine Revenue (Million USD) by Regions (2015-2020)

Table 63. Global Covid-19 Vaccine Revenue Market Share by Regions (2015-2020)

Table 64. North America Covid-19 Vaccine Revenue by Countries (2015-2020)

Table 65. North America Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Table 66. Europe Covid-19 Vaccine Revenue (Million USD) by Countries (2015-2020)

Table 67. Asia-Pacific Covid-19 Vaccine Revenue (Million USD) by Countries (2015-2020)

Table 68. South America Covid-19 Vaccine Revenue by Countries (2015-2020)

Table 69. South America Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Table 70. Middle East and Africa Covid-19 Vaccine Revenue (Million USD) by Countries (2015-2020)

Table 71. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Table 72. Global Covid-19 Vaccine Revenue (Million USD) by Type (2015-2020)

Table 73. Global Covid-19 Vaccine Revenue Share by Type (2015-2020)

Table 74. Global Covid-19 Vaccine Revenue Forecast by Type (2021-2025)

Table 75. Global Covid-19 Vaccine Revenue by Application (2015-2020)

Table 76. Global Covid-19 Vaccine Revenue Share by Application (2015-2020)

Table 77. Global Covid-19 Vaccine Revenue Forecast by Application (2021-2025)

Table 78. Global Covid-19 Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Covid-19 Vaccine Picture

Figure 2. Global Covid-19 Vaccine Revenue Market Share by Type in 2019

Figure 3. DNA Picture

Figure 4. Non-replicating Viral Vector Picture

Figure 5. Protein Subunit Picture

Figure 6. RNA Picture

Figure 7. Others Picture

Figure 8. Covid-19 Vaccine Revenue Market Share by Application in 2019

Figure 9. Adults Picture

Figure 10. Children Picture

Figure 11. Global Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2015-2025)

Figure 12. North America Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. Europe Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Asia-Pacific Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. South America Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 16. Middle East and Africa Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 17. Global Covid-19 Vaccine Revenue (Million USD) and Growth Rate (2015-2025)

Figure 18. Global Covid-19 Vaccine Revenue Share by Players in 2019

Figure 19. Global Top 5 Players Covid-19 Vaccine Revenue Market Share in 2019

Figure 20. Global Top 10 Players Covid-19 Vaccine Revenue Market Share in 2019

Figure 21. Key Players Market Share Trend

Figure 22. Global Covid-19 Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 23. Global Covid-19 Vaccine Revenue Market Share by Regions (2015-2020)

Figure 24. Global Covid-19 Vaccine Revenue Market Share by Regions in 2018

Figure 25. North America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 26. Europe Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 27. Asia-Pacific Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 28. South America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 29. Middle East and Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 30. North America Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Figure 31. North America Covid-19 Vaccine Revenue Market Share by Countries in 2019

Figure 32. USA Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 33. Canada Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 34. Mexico Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 35. Europe Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Figure 36. Europe Covid-19 Vaccine Revenue Market Share by Countries in 2019

Figure 37. Germany Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 38. UK Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 39. France Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 40. Russia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 41. Italy Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 42. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Figure 43. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Countries in 2019

Figure 44. China Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 45. Japan Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 46. Korea Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 47. India Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 48. Southeast Asia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 49. South America Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Figure 50. South America Covid-19 Vaccine Revenue Market Share by Countries in 2019

Figure 51. Brazil Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 52. Argentina Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 53. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Countries (2015-2020)

Figure 54. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Countries in 2019

Figure 55. Saudi Arabia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 56. UAE Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 57. Egypt Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 58. South Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)

Figure 59. Global Covid-19 Vaccine Revenue Share by Type (2015-2020)

Figure 60. Global Covid-19 Vaccine Revenue Share by Type in 2019

Figure 61. Global Covid-19 Vaccine Market Share Forecast by Type (2021-2025)

Figure 62. Global DNA Revenue Growth Rate (2015-2020)

Figure 63. Global Non-replicating Viral Vector Revenue Growth Rate (2015-2020)

Figure 64. Global Protein Subunit Revenue Growth Rate (2015-2020)

Figure 65. Global RNA Revenue Growth Rate (2015-2020)

Figure 66. Global Others Revenue Growth Rate (2015-2020)

Figure 67. Global Covid-19 Vaccine Revenue Share by Application (2015-2020)

Figure 68. Global Covid-19 Vaccine Revenue Share by Application in 2019

Figure 69. Global Covid-19 Vaccine Market Share Forecast by Application (2021-2025)

Figure 70. Global Adults Revenue Growth Rate (2015-2020)

Figure 71. Global Children Revenue Growth Rate (2015-2020)

Figure 72. Global Covid-19 Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 73. Global Covid-19 Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 74. Global Covid-19 Vaccine Revenue Market Share Forecast by Regions (2021-2025)

Figure 75. North America Covid-19 Vaccine Revenue Market Forecast (2021-2025)

Figure 76. Europe Covid-19 Vaccine Revenue Market Forecast (2021-2025)

Figure 77. Asia-Pacific Covid-19 Vaccine Revenue Market Forecast (2021-2025)

Figure 78. South America Covid-19 Vaccine Revenue Market Forecast (2021-2025)

Figure 79. Middle East and Africa Covid-19 Vaccine Revenue Market Forecast (2021-2025)

Figure 80. Sales Channel: Direct Channel vs Indirect Channel